AcelRx CEO mentioned.

Furthermore, FDA provided clearness on the development requirements to join up ARX-02 for the broader indication of chronic breakthrough pain in opioid-tolerant patients, where we believe that ARX-02 can impact on the lives of a broader selection of opioid-tolerant patients. .. AcelRx completes ARX-02 End-of-Phase 2 meeting with FDA for malignancy breakthrough pain management system AcelRx Pharmaceuticals, Inc. FDA reviewed a bundle based on the previously announced positive Stage 2 clinical study leads to day for ARX-02 and provided AcelRx with help with the Phase 3 system design and NDA requirements.Don’t worry if hearing particular tunes or doing certain items is painful since it brings back remembrances of the person that you lost. It’s natural to feel in this manner. After a while, it becomes less painful. Know that you can feel better over time. Talk about it all when you can. Some individuals find it helpful to tell the tale of their loss or talk about their feelings. But sometimes a person doesn’t feel like talking about a loss, and that’s OK, too. No one should feel pressured to talk. Even though you don’t feel just like talking, find ways to express your emotions and thoughts.